Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Drug of Abuse (DOA) Testing Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Urine
      • 1.3.3 Saliva
      • 1.3.4 Hair
      • 1.3.5 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Drug of Abuse (DOA) Testing Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Laboratories
      • 1.4.4 Workplace
      • 1.4.5 At-Home
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Drug of Abuse (DOA) Testing Production Value 2014-2025
      • 2.1.2 Global Drug of Abuse (DOA) Testing Production 2014-2025
      • 2.1.3 Global Drug of Abuse (DOA) Testing Capacity 2014-2025
      • 2.1.4 Global Drug of Abuse (DOA) Testing Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Drug of Abuse (DOA) Testing Market Size CAGR of Key Regions
      • 2.2.2 Global Drug of Abuse (DOA) Testing Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Drug of Abuse (DOA) Testing Capacity by Manufacturers
      • 3.1.2 Global Drug of Abuse (DOA) Testing Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Drug of Abuse (DOA) Testing Revenue by Manufacturers (2014-2019)
      • 3.2.2 Drug of Abuse (DOA) Testing Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
    • 3.3 Drug of Abuse (DOA) Testing Price by Manufacturers
    • 3.4 Key Manufacturers Drug of Abuse (DOA) Testing Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Drug of Abuse (DOA) Testing Market
    • 3.6 Key Manufacturers Drug of Abuse (DOA) Testing Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Urine Production and Production Value (2014-2019)
      • 4.1.2 Saliva Production and Production Value (2014-2019)
      • 4.1.3 Hair Production and Production Value (2014-2019)
      • 4.1.4 Others Production and Production Value (2014-2019)
    • 4.2 Global Drug of Abuse (DOA) Testing Production Market Share by Type
    • 4.3 Global Drug of Abuse (DOA) Testing Production Value Market Share by Type
    • 4.4 Drug of Abuse (DOA) Testing Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Drug of Abuse (DOA) Testing Consumption by Application

    6 Production by Regions

    • 6.1 Global Drug of Abuse (DOA) Testing Production (History Data) by Regions 2014-2019
    • 6.2 Global Drug of Abuse (DOA) Testing Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Drug of Abuse (DOA) Testing Production Growth Rate 2014-2019
      • 6.3.2 United States Drug of Abuse (DOA) Testing Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Drug of Abuse (DOA) Testing Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Drug of Abuse (DOA) Testing Production Growth Rate 2014-2019
      • 6.4.2 European Union Drug of Abuse (DOA) Testing Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Drug of Abuse (DOA) Testing Import & Export
    • 6.5 China
      • 6.5.1 China Drug of Abuse (DOA) Testing Production Growth Rate 2014-2019
      • 6.5.2 China Drug of Abuse (DOA) Testing Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Drug of Abuse (DOA) Testing Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Drug of Abuse (DOA) Testing Consumption by Regions

    • 7.1 Global Drug of Abuse (DOA) Testing Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Drug of Abuse (DOA) Testing Consumption by Type
      • 7.2.2 United States Drug of Abuse (DOA) Testing Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Drug of Abuse (DOA) Testing Consumption by Type
      • 7.3.2 European Union Drug of Abuse (DOA) Testing Consumption by Application
    • 7.4 China
      • 7.4.1 China Drug of Abuse (DOA) Testing Consumption by Type
      • 7.4.2 China Drug of Abuse (DOA) Testing Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Drug of Abuse (DOA) Testing Consumption by Type
      • 7.5.2 Rest of World Drug of Abuse (DOA) Testing Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Siemens
      • 8.1.1 Siemens Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Drug of Abuse (DOA) Testing
      • 8.1.4 Drug of Abuse (DOA) Testing Product Introduction
      • 8.1.5 Siemens Recent Development
    • 8.2 Merck
      • 8.2.1 Merck Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Drug of Abuse (DOA) Testing
      • 8.2.4 Drug of Abuse (DOA) Testing Product Introduction
      • 8.2.5 Merck Recent Development
    • 8.3 Roche
      • 8.3.1 Roche Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Drug of Abuse (DOA) Testing
      • 8.3.4 Drug of Abuse (DOA) Testing Product Introduction
      • 8.3.5 Roche Recent Development
    • 8.4 Thermo Fisher Scientific
      • 8.4.1 Thermo Fisher Scientific Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Drug of Abuse (DOA) Testing
      • 8.4.4 Drug of Abuse (DOA) Testing Product Introduction
      • 8.4.5 Thermo Fisher Scientific Recent Development
    • 8.5 Bio-Rad
      • 8.5.1 Bio-Rad Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Drug of Abuse (DOA) Testing
      • 8.5.4 Drug of Abuse (DOA) Testing Product Introduction
      • 8.5.5 Bio-Rad Recent Development
    • 8.6 Abbott
      • 8.6.1 Abbott Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Drug of Abuse (DOA) Testing
      • 8.6.4 Drug of Abuse (DOA) Testing Product Introduction
      • 8.6.5 Abbott Recent Development
    • 8.7 Quest Diagnostics
      • 8.7.1 Quest Diagnostics Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Drug of Abuse (DOA) Testing
      • 8.7.4 Drug of Abuse (DOA) Testing Product Introduction
      • 8.7.5 Quest Diagnostics Recent Development
    • 8.8 Express Diagnostics Int'l
      • 8.8.1 Express Diagnostics Int'l Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Drug of Abuse (DOA) Testing
      • 8.8.4 Drug of Abuse (DOA) Testing Product Introduction
      • 8.8.5 Express Diagnostics Int'l Recent Development
    • 8.9 Psychemedics
      • 8.9.1 Psychemedics Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Drug of Abuse (DOA) Testing
      • 8.9.4 Drug of Abuse (DOA) Testing Product Introduction
      • 8.9.5 Psychemedics Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Drug of Abuse (DOA) Testing Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Drug of Abuse (DOA) Testing Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Drug of Abuse (DOA) Testing Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Drug of Abuse (DOA) Testing Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Drug of Abuse (DOA) Testing Production Forecast by Type
      • 9.7.2 Global Drug of Abuse (DOA) Testing Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Drug of Abuse (DOA) Testing Sales Channels
      • 10.2.2 Drug of Abuse (DOA) Testing Distributors
    • 10.3 Drug of Abuse (DOA) Testing Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Drugs of abuse testing is the detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat.
      During the forecast period, the Drug of Abuse (DOA) Testing market is expected to witness the fastest growth in the APAC region.
      In 2019, the market size of Drug of Abuse (DOA) Testing is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Drug of Abuse (DOA) Testing.

      This report studies the global market size of Drug of Abuse (DOA) Testing, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Drug of Abuse (DOA) Testing production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Siemens
      Merck
      Roche
      Thermo Fisher Scientific
      Bio-Rad
      Abbott
      Quest Diagnostics
      Express Diagnostics Int'l
      Psychemedics

      Market Segment by Product Type
      Urine
      Saliva
      Hair
      Others

      Market Segment by Application
      Hospitals
      Laboratories
      Workplace
      At-Home

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Drug of Abuse (DOA) Testing status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Drug of Abuse (DOA) Testing manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Drug of Abuse (DOA) Testing are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now